Teikoku Pharma

Teikoku Pharma is a wholly-owned subsidiary of Japan's Teikoku Seiyaku Co., Ltd. A global pharmaceutical company focused on developing novel, first-class therapeutic solutions for unmet patient needs. Teikoku also develops and manufactures pharmaceuticals based on proprietary delivery platform technologies. Teikoku Pharma's key products include: Lidoderm® (5% lidocaine patch) for post-herpetic neuralgia in the United States, Docetaxel® in Europe and Latin America, and Docetaxel Injection (alcohol-free).